Manuscripts submitted to the Pharma Research Bulletin (Pharm. Res. Bull.) will be considered for publication with the understanding that they are submitted exclusively to Pharm. Res. Bull. and have not been previously published, simultaneously submitted, or accepted elsewhere. All submissions undergo an independent and unbiased double-blinded peer-review process. In the initial phase, manuscripts are screened by the editorial board to ensure they meet journal guidelines and standards. If deemed suitable, they are forwarded for peer review. Typically, manuscripts are reviewed by at least two independent reviewers following the editorial board’s assessment. Reviewer feedback, along with the editorial board’s decision, is then communicated to the authors for further action. The submitted manuscripts are treated as confidential documents. We expect our Board of Reviewing Editors and reviewers to treat manuscripts as confidential material as well. Authors are welcome to suggest experts in their field as potential referees to evaluate their manuscripts.